CompletedPhase 2NCT00973128

Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitário Professor Edgard Santos
Principal Investigator
Roque P Almeida, MD, PhD
Hospital Universitário Prof Edgard Santos-UFBA
Intervention
GMCSF plus Antimony reduced dose(drug)
Enrollment
40 enrolled
Eligibility
15-50 years · All sexes
Timeline
2004 – 2007

Study locations (1)

Collaborators

Fundação de Amparo à Pesquisa do Estado da Bahia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00973128 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials